Comparison Chart Scholar Rock Holding Corporation

Stocks

SRRK

US80706P1030

Biotechnology & Medical Research

Market Closed - Nasdaq 23:00:00 14/09/2026 +03			5-day change	1st Jan Change
51.85 ^USD	-6.42%		-6.29%	+17.71%

07:23pm	Scholar Rock's Early FDA Approval on Spinal Muscular Atrophy Drug Seen as 'Positive Surprise,' UBS Says	MT
06:13pm	Wedbush Adjusts Price Target on Scholar Rock to $70 From $64, Keeps Outperform Rating	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	SCHOLAR ROCK HOLDING CORPORATION	Bio Therapeutic Drugs	-6.42%	-6.29%	+17.71%	+63.72%	+33.29%	6.75B